BlackRock, Inc. 13D and 13G filings for Quest Diagnostics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Quest Diagnostics Incorporated DGX | BlackRock Inc. BLK | 9,308,815 8.400% | -1,269,210 (-12.00%) | Filing |
| 2024-01-24 5:23 pm Sale | 2023-12-31 | 13G | Quest Diagnostics Incorporated DGX | BlackRock Inc. BLK | 10,578,025 9.400% | -1,813,302 (-14.63%) | Filing |
| 2023-01-23 3:52 pm Sale | 2022-12-31 | 13G | Quest Diagnostics Incorporated DGX | BlackRock Inc. BLK | 12,391,327 10.900% | -416,297 (-3.25%) | Filing |
| 2022-04-08 09:57 am Purchase | 2022-03-31 | 13G | Quest Diagnostics Incorporated DGX | BlackRock Inc. BLK | 12,807,624 10.700% | 1,171,242 (+10.07%) | Filing |
| 2022-02-07 4:40 pm Purchase | 2021-12-31 | 13G | Quest Diagnostics Incorporated DGX | BlackRock Inc. BLK | 11,636,382 9.500% | 172,167 (+1.50%) | Filing |